VOLUME 9 (2018)
View Archive »
About The Cover
The cover for issue 65 of Oncotarget features Figure 5, "Waterfall plot showing response by % change in tumor size after Y-90 radioembolization," by Dendy, et al.
|
|
Table of Contents
News
|
| Distinguishing mechanisms of adverse drug reactions from mechanisms of actions of drugs |
|
https://doi.org/10.18632/oncotarget.25968
|
| 32404-32405 |
Editorial
|
| Clinical utility of chromatin analysis |
|
https://doi.org/10.18632/oncotarget.25991
|
| 32406-32407 |
Research Papers
|
| An intestinal stem cell niche in Apc mutated neoplasia targetable by CtBP inhibition |
|
https://doi.org/10.18632/oncotarget.25784
|
| 32408-32418 |
|
| A novel molecular mechanism for a long noncoding RNA PCAT92 implicated in prostate cancer |
|
https://doi.org/10.18632/oncotarget.25940
|
| 32419-32434 |
|
| Integrin α2β1 decelerates proliferation but promotes survival and invasion of prostate cancer cells |
|
https://doi.org/10.18632/oncotarget.25945
|
| 32435-32447 |
|
| “Two hits one stoneâ€; increased efficacy of cisplatinbased therapies by targeting PCNA’s role in both DNA repair and cellular signaling |
|
https://doi.org/10.18632/oncotarget.25963
|
| 32448-32465 |
|
| SPIN1 is a protooncogene and SPIN3 is a tumor suppressor in human seminoma |
|
https://doi.org/10.18632/oncotarget.25977
|
| 32466-32477 |
|
| Zac1 regulates IL11 expression in osteoarthritis |
|
https://doi.org/10.18632/oncotarget.25980
|
| 32478-32495 |
|
| Therapeutic targeting of Aurora A kinase in Philadelphia chromosomepositive ABL tyrosine kinase inhibitorresistant cells |
|
https://doi.org/10.18632/oncotarget.25985
|
| 32496-32506 |
|
| miR193b and miR30c1* inhibit whereas miR5765p enhances melanoma cell invasion in vitro |
|
https://doi.org/10.18632/oncotarget.25986
|
| 32507-32522 |
|
| Genomic mutations and histopathologic biomarkers in Y90 radioembolization for chemorefractory colorectal liver metastases |
|
https://doi.org/10.18632/oncotarget.25992
|
| 32523-32533 |
Reviews
|
| Approaches to the discovery of noninvasive urinary biomarkers of prostate cancer |
|
https://doi.org/10.18632/oncotarget.25946
|
| 32534-32550 |
Retraction
|
| Retraction: MicroRNA3715p targets SOX2 in gastric cancer |
|
https://doi.org/10.18632/oncotarget.26037
|
| 32551-32551 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLCß
